Letters to the editor (multiple letters)

Clinical Therapeutics

Volumn 23, Issue 12, 2001, Pages 2050-2055

  Subbiah, Ponni ^c   Schwam, Elias M ^a   Côté, Christine ^b  

^a PFIZER INC   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; GALANTAMINE; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

ADVERSE DRUG REACTION; ALZHEIMER DISEASE; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFECT; DRUG HALF LIFE; DRUG SAFETY; DRUG USE; HUMAN; LETTER; PRACTICE GUIDELINE; PRESCRIPTION; DRUG INTERACTION; METABOLISM; NOTE;

ALZHEIMER DISEASE; DRUG INTERACTIONS; GALANTAMINE; HUMANS; INDANS; NOOTROPIC AGENTS; PIPERIDINES;

EID: 0035692884     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80157-0     Document Type: Letter

References (0)